Hudson Bay Capital Management
AMED

Hudson Bay Capital Management’s Amedisys AMED Stock Holding History

Hudson Bay Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-225,000
Closed -$22.1M – 1228
2025
Q2 		$22.1M Buy
+225,000
New +$21.3M 0.08% 195

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hudson Bay Capital Management's AMED Position: Q3 2025 in Review

Hudson Bay Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 197,126 shares — an estimated $19.4M sold.

Hudson Bay Capital Management first reported a position in AMED in Q4 2016 and held it in 13 quarters. The position peaked at $26.3M in Q2 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Hudson Bay Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 197,126 Amedisys shares in Q3 2025, an estimated $19.4M.
  • Hudson Bay Capital Management first reported a position in Amedisys in Q4 2016 and held it in 13 quarters.
  • Hudson Bay Capital Management's Amedisys position peaked at $26.3M in Q2 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.